A Degarelix Trial in Patients With Prostate Cancer
Status:
Terminated
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
A phase III extension trial comparing the efficacy and safety of degarelix 3 month depot with
the established therapy Zoladex 3 month implant in patients with prostate cancer.